Seqens news

The partnership enables PEKK production for long-term medical implants, leveraging expertise in polymer synthesis and global distribution networks.

Seqens expands its reach in South Asia, partnering with KK India Petroleum to distribute lubricant additives and support local customers in formulation and troubleshooting.

Seqens will develop and produce Pleryon's osteoarthritis polymer at its upgraded French facility, enhancing GMP capabilities for medical and pharmaceutical applications.

The isopropanol plant expansion will be completed by Q1 2022, increasing capacity by 70% to 120 Kt/year. Energy consumption will drop 66%, cutting CO2 emissions by 10 Kt annually.

The new unit, supported by France Relance, will produce 10,000 tonnes of paracetamol annually by 2023, using innovative, eco-friendly processes to meet growing demand and enhance EU health sovereignty.

The new facility in Roussillon will produce 45,000 tons of isopropanol annually, enhancing energy efficiency and supporting various industries with multiple grades of the solvent.

The new plant will boost IPA production by 70%, adding 50,000 metric tons annually. It will support growing demand and enable increased production of specialty products like IPAC and DIPE.

The new DIPE unit uses an innovative, eco-friendly process, boosting the range of oxygenated solvents for pharmaceuticals, resins, coatings, and wastewater treatment, with a 5,000-ton capacity.

A new isopropyl acetate unit will enhance product offerings in pharmaceuticals, cosmetics, and food, aligning with sustainable development and aiming for market leadership within five years.